Cancer clinical trials in the region Bretagne

211 currently recruiting clinical trials
Region Bretagne

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3 Prostate cancer #NCT06629779 #2024-511652-40-00
Adenocarcinoma Metastatic Castration-resistant None Systemic Treatment-Naive
Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Pfizer
Phase 3 Stomach and esophageal cancer #NCT06644781 #2023-509630-19-00
Esophagus Squamous cell carcinoma Locally Advanced Metastatic 1 Immunotherapy Chemotherapy
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Daiichi Sankyo
Phase 3 Lung cancer #NCT06119581 #2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C None Systemic Treatment-Naive
BRAF EGFR HER2 MET NTRK-1/2/3 RET ROS-1 Immunotherapy Chemotherapy Targeted therapy
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Eli Lilly et compagnie
Phase 3 Breast cancer #NCT06382948
HER2 Negative HR Positive Locally Advanced Metastatic ESR 1 2 Targeted therapy Hormone therapy
ESR Systemic Treatment-Naive Chemotherapy
CARIO Imagerie Médicale site de Plérin (Plérin)
MedSIR